Source: International Congress 2019 – Insights into paediatric bronchology
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
O. Cimen (Ankara, Turkey), N. Emiralioglu (Ankara, Turkey), M. Gharibzadehhizal (Ankara, Turkey), Y. Bayindir (Ankara, Turkey), S. Eryilmazpolat (Ankara, Turkey), D. Ademhan (Ankara, Turkey), B. Oguz (Ankara, Turkey), D. Orhan (Ankara, Turkey), N. Ozcan (Ankara, Turkey), B. Aydin (Ankara, Turkey), T. Soyer (Ankara, Turkey), E. Yalcin (Ankara, Turkey), D. Dogru (Ankara, Turkey), U. Ozcelik (Ankara, Turkey), N. Kiper (Ankara, Turkey). Severe Langerhans Cell Histiocytosis with Pulmonary Involvement. 1064

Member's Comments

No comment yet.

Related content which might interest you: Cytokine profiling in Pulmonary Langerhans Cell Histiocytosis: novel insights into pathogenesis. Source: International Congress 2018 – New insights in rare diffuse parenchymal lung diseases (DPLDs) in adults and children Year: 2018 Pulmonary Hypertension in Pulmonary Langerhans Cell Histiocytosis: prevalence and the role of Cardiopulmonary Exercise Testing and echocardiogram in predicting it Source: International Congress 2019 – Innovative approaches for management and treatment of rare diffuse parenchymal lung diseases Year: 2019 Pulmonary Langerhans‘ cell histiocytosis Source: Eur Respir J 2006; 28: Suppl. 50, 826s Year: 2006 Pulmonary Langerhans cell histiocytosis Source: Annual Congress 2008 - PG5 - Interstitial lung diseases: selected orphan diseases Year: 2008 Clinical characteristics of a Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH)  Cohort Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key Year: 2020 Pulmonary Langerhans' cell histiocytosis Source: Eur Respir Mon; 2009: 46: 155–175 Year: 2009 Primary Pulmonary Amyloidosis Source: International Congress 2018 – Sarcoidosis, interstitial lung diseases and various clinical problems Year: 2018 Idiopathic Pulmonary Haemosiderosis; Factors That Effect Prognosis Source: Virtual Congress 2020 – Tip the hat to paediatric bronchology Year: 2020 Paediatric pulmonary Langerhans cell histiocytosis Source: Breathe, 16 (2) 200003; 10.1183/20734735.0003-2020 Year: 2020 Clinical Features and Prognosis of Acute exacerbation of Connective Tissue Diseases Associated Pulmonary Fibrosis------ Comparision with Idiopathic Pulmonary Fibrosis Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment Year: 2017 Association between Pulmonary Infections and the Prognosis in Patients with Idiopathic Pulmonary Fibrosis Source: Virtual Congress 2021 – Interstitial lung disease around the world Year: 2021 Lung transplantation for pulmonary Langerhans‘ cell histiocytosis Source: Eur Respir J 2005; 26: Suppl. 49, 635s Year: 2005 Treatment of Idiopathic Pulmonary Fibrosis Source: Guideline 2015 Year: 2015 Platelet activation indices in patients with Idiopathic Pulmonary Fibrosis Source: International Congress 2014 – ILDs 5 Year: 2014 Predictors of Progression in Patients with Pulmonary Sarcoidosis Source: Virtual Congress 2020 – Clinical issues in granulomatous lung diseases Year: 2020 Differential Expression of Plasma Metabolites in Patients with Pulmonary Sarcoidosis is Associated with Clinical Behavior Source: International Congress 2018 – Sarcoidosis: from basic research to patient outcomes Year: 2018 Development of Pulmonary Arteriovenous Malformations and Occurrence of Neurological Complications in patients with Hereditary Haemorrhagic Telangiectasia with isolated micronodules and/or intrapulmonary shunt at first screening Source: International Congress 2019 – Rare and ultra-rare diseases and the lungs: updates and new perspectives Year: 2019 Pulmonary histiocytosis triggered by marijuana- and nicotine-abuse Source: Eur Respir J 2002; 20: Suppl. 38, 338s Year: 2002 Chemotherapy in patients with pulmonary Langerhans cell histiocytosis Source: International Congress 2018 – Progress in rare interstitial lung diseases Year: 2018